Cite
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
MLA
Russell, F. M., et al. “Safety and Immunogenicity of the 23-Valent Pneumococcal Polysaccharide Vaccine at 12 Months of Age, Following One, Two, or Three Doses of the 7-Valent Pneumococcal Conjugate Vaccine in Infancy.” Vaccine, vol. 28, no. 18, Apr. 2010, pp. 3086–94. EBSCOhost, https://doi.org/10.1016/j.vaccine.2010.02.065.
APA
Russell, F. M., Licciardi, P. V., Balloch, A., Biaukula, V., Tikoduadua, L., Carapetis, J. R., Nelson, J., Jenney, A. W. J., Waqatakirewa, L., Colquhoun, S., Cheung, Y. B., Tang, M. L. K., & Mulholland, E. K. (2010). Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy. Vaccine, 28(18), 3086–3094. https://doi.org/10.1016/j.vaccine.2010.02.065
Chicago
Russell, F.M., P.V. Licciardi, A. Balloch, V. Biaukula, L. Tikoduadua, J.R. Carapetis, J. Nelson, et al. 2010. “Safety and Immunogenicity of the 23-Valent Pneumococcal Polysaccharide Vaccine at 12 Months of Age, Following One, Two, or Three Doses of the 7-Valent Pneumococcal Conjugate Vaccine in Infancy.” Vaccine 28 (18): 3086–94. doi:10.1016/j.vaccine.2010.02.065.